Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...

The 42-year-old made a dress with 1000 syringes filled with fake blood. She fixed the syringe with the sharp needles on her fabric and it gave her an intimidating look. She combined her attire with ...

Dr Elizabeth Robertson, Diabetes UK’s director of research, said: “Dr Reith’s idea, and her determination to bring the insulin pen to life, changed the face of insulin therapy and diabetes care ...

“Doctor Odyssey,” TV hitmaker Ryan Murphy’s new network medical drama set on a cruise ship, has already featured a syphilis outbreak, a nose falling off a woman’s face, a man overboard, a ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug left to fill her prescription. Her neighborhood Fred Meyer pharmacy in ...

We couldn’t be happier to see Dr Sheila Reith, CBE honoured at the Pride of Britain Awards for improving the lives of millions of people with diabetes worldwide.

This meant that Sheila fully understood the practical difficulties of injecting insulin using a glass syringe and re-usable steel needle which had to be sharpened, sterilised and carried in a ...

Life with diabetes usually includes many injections of the blood sugar–controlling hormone insulin. Recent research investigating a once-weekly shot finds it might help lessen the burden a bit ...

Now, scientists have made a major breakthrough in developing what has been long called the “holy grail” diabetes treatments — a “smart” insulin that responds in real time to fluctuations in one’s ...